Literature DB >> 25829275

Muscular dystrophy: New exon-skipping strategy rescues dystrophin.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25829275     DOI： 10.1038/nrd4587

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.

Authors:  Aurélie Goyenvalle; Graziella Griffith; Arran Babbs; Samir El Andaloussi; Kariem Ezzat; Aurélie Avril; Branislav Dugovic; Rémi Chaussenot; Arnaud Ferry; Thomas Voit; Helge Amthor; Claudia Bühr; Stefan Schürch; Matthew J A Wood; Kay E Davies; Cyrille Vaillend; Christian Leumann; Luis Garcia
Journal:  Nat Med       Date:  2015-02-02       Impact factor: 53.440
  1 in total
  2 in total

1.  Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models.

Authors:  Alexander Morrison-Nozik; Saptarsi M Haldar
Journal:  Methods Mol Biol       Date:  2018

2.  Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability.

Authors:  Elizabeth M McNally; Eugene J Wyatt
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.